0001236031-17-000011.txt : 20170725
0001236031-17-000011.hdr.sgml : 20170725
20170725153511
ACCESSION NUMBER: 0001236031-17-000011
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170724
FILED AS OF DATE: 20170725
DATE AS OF CHANGE: 20170725
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PRICHEP PATRICIA B
CENTRAL INDEX KEY: 0001236215
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11889
FILM NUMBER: 17980387
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEL SCI CORP
CENTRAL INDEX KEY: 0000725363
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 840916344
STATE OF INCORPORATION: CO
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 8229 BOONE BLVD .
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
BUSINESS PHONE: 7035069460
MAIL ADDRESS:
STREET 1: 8229 BOONE BLVD.
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
FORMER COMPANY:
FORMER CONFORMED NAME: INTERLEUKIN 2 INC
DATE OF NAME CHANGE: 19880317
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2017-07-24
0
0000725363
CEL SCI CORP
cvm
0001236215
PRICHEP PATRICIA B
0
1
0
0
Senior Vice President
Convertible Note
2.29
2017-07-24
4
A
0
10917
25000
A
2017-07-24
2017-12-22
Common Stock
10917
41505
D
Series NN Warrant
2.52
2017-07-24
4
A
0
10917
0.01
A
2017-07-24
2022-07-24
Common Stock
10917
52422
D
Ms. Prichep participated in an offering and purchased a note in the principal amount of $25,000, as well as the Series NN warrant. Shares issuable upon the conversion of the note or the exercise of the warrant will be restricted securities unless registered.
Patricia Prichep
2017-07-25